Skip to main content
. 2020 Nov 13;4:100117. doi: 10.1016/j.ajpc.2020.100117

Fig. 3.

Fig. 3

The percentage of patients with an event in primary and secondary ASCVD prevention – a comparison using data from reduce-it and declare-timi 58

Abbreviations: REDUCE-IT – reduction of cardiovascular events with icosapent ethyl-intervention trial; declare-timi 58 – dapaglifozin and cardiovascular outcomes in type 2 diabetes trial; ASCVD – atherosclerotic cardiovascular disease; CV – cardiovascular; MI – myocardial infarction.